The gene RAD51C is a “cancer protection” gene that encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known to increase the risk of breast ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, finding over 3,000 harmful genetic changes that could potentially disrupt ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the 'cancer protection' gene RAD51C, finding over 3,000 harmful genetic changes that could potentially disrupt its ...

Researchers from the Wellcome Sanger Institute and their collaborators focused on the ‘cancer protection’ gene RAD51C, known to increase ovarian cancer risk six-fold and risk of aggressive subtypes of ...

Reporting in Nature, Kumar and colleagues have now developed a method to target small-interfering RNA (siRNA) to the CNS, providing a safe and non-invasive approach for the delivery of this new ...

Welcome to the 3 rd Annual RNAi – Based Therapeutics Summit: Overcoming Barriers for Targeted siRNA Therapeutics Built with biopharmaceutical industry insights, this in person conference will ...

Ibsa waa'ee suuraa, Manguddoota Booranaa yeroo sirna Gadaa. 18 Amajjii 2021 Hariiroo waliin jireenya namootaa keessatti namni tokko itti yaadees haa ta'u tasa lubbuu nama kan biraa balleessuu dandaha.

New research identifies specific genetic changes that can increase a person's risk of breast and ovarian cancers, to help guide clinical decision-making. Scientists have pinpointed thousands of ...